|
|
|
Notifications
|
|
|
|
http://www.gires.org.uk/assets/Medpro-Assets/AMA122.pdf
Introduced by: Resident and Fellow Section, Massachusettes Medical Society, California
Medical Association, Medical Society of the State of New York
Subject: Removing Financial Barriers to Care for Transgender Patients
Referred to: Reference Committee A
Whereas, The American Medical Association opposes discrimination 1 on the basis of
2 gender identity1 and
3
4 Whereas, Gender Identity Disorder (GID) is a serious medical condition recognized as
5 such in both the Diagnostic and Statistical Manual of Mental Disorders (4th Ed., Text
6 Revision) (DSM-IV-TR) and the International Classification of Diseases (10th Revision),2
7 and is characterized in the DSM-IV-TR as a persistent discomfort with one’s assigned
8 sex and with one’s primary and secondary sex characteristics, which causes intense
9 emotional pain and suffering;3 and
10
11 Whereas, GID, if left untreated, can result in clinically significant psychological distress,
12 dysfunction, debilitating depression and, for some people without access to appropriate
13 medical care and treatment, suicidality and death;4 and
14
15 Whereas, The World Professional Association For Transgender Health, Inc. (“WPATH”)
16 is the leading international, interdisciplinary professional organization devoted to the
17 understanding and treatment of gender identity disorders,5 and has established
18 internationally accepted Standards of Care 6 for providing medical treatment for people
19 with GID, including mental health care, hormone therapy and sex reassignment surgery,
20 which are designed to promote the health and welfare of persons with GID and are
21 recognized within the medical community to be the standard of care for treating people
22 with GID; and
23
24 Whereas, An established body of medical research demonstrates the effectiveness and
25 medical necessity of mental health care, hormone therapy and sex reassignment
26 surgery as forms of therapeutic treatment for many people diagnosed with GID; 7 and
27
28 Whereas, Health experts in GID, including WPATH, have rejected the myth that such
29 treatments are “cosmetic” or “experimental” and have recognized that these treatments
30 can provide safe and effective treatment for a serious health condition;7 and.................................................................view link above for continuation
